![](/img/cover-not-exists.png)
New risk prediction models in England may lead to targeted PCSK9 inhibitor treatment, for patients with established cardiovascular disease
Tillmann, TaaviJournal:
European Journal of Preventive Cardiology
DOI:
10.1177/2047487320904513
Date:
February, 2020
File:
PDF, 147 KB
2020